Enhanced production of hyperthermophilic Pyrococcus furiosus β-glucosidase in Corynebacterium glutamicum by optimization of the promoter, vector backbone, and His-tag location
IF 3.7 3区 生物学Q2 BIOTECHNOLOGY & APPLIED MICROBIOLOGY
Mehmet Emre Erkanli , Ryu Hong Park , Jingwei Liu , Gunhyeong Lee , Amulya Hota , Jehyeon Lee , Chaehyun Ryu , Ki Jun Jeong , Jin Ryoun Kim
{"title":"Enhanced production of hyperthermophilic Pyrococcus furiosus β-glucosidase in Corynebacterium glutamicum by optimization of the promoter, vector backbone, and His-tag location","authors":"Mehmet Emre Erkanli , Ryu Hong Park , Jingwei Liu , Gunhyeong Lee , Amulya Hota , Jehyeon Lee , Chaehyun Ryu , Ki Jun Jeong , Jin Ryoun Kim","doi":"10.1016/j.enzmictec.2025.110725","DOIUrl":null,"url":null,"abstract":"<div><div>A hyperthermophilic β-glucosidase from <em>Pyrococcus furiosus</em> (PfBGL) is a highly stable and active glycoside hydrolase, well-suited for a wide range of applications. Although PfBGL has been successfully expressed in <em>Escherichia coli</em>, the use of this host limits its applicability in the healthcare and food processing industries due to safety concerns associated with <em>E. coli</em>-based expression systems. Recently, <em>Corynebacterium glutamicum</em> has emerged as a safe and versatile microbial platform for the expression of recombinant proteins used in food processing, pharmaceutical development, therapeutic enzyme production, and probiotic applications. Despite these advantages, heterologous expression in <em>C. glutamicum</em> is often hindered by low protein yields, and PfBGL expression in this host has not been previously explored. In this study, we report for the first time the production of PfBGL in <em>C. glutamicum</em>, achieving a 15-fold enhancement through the optimization of the promoter, the vector backbone, and the His-tag location. Among four different promoters, the <em>P</em><sub>trc</sub> promoter with <em>RBS</em><sub>T7</sub> yielded the highest PfBGL expression. For the <em>P</em><sub>trc</sub>-<em>RBS</em><sub>T7</sub> combination, the PfBGL expression levels further varied depending on the vector backbone. Interestingly, placing the His-tag at the N-terminus of PfBGL not only increased its expression in <em>C. glutamicum</em>, but also enhanced its enzymatic activity (<em>k</em><sub>cat</sub>/<em>K</em><sub>m</sub>), when compared to C-terminal tagging. Overall, this study showcases a simple yet effective strategy at both genetic and protein levels to enhance PfBGL production in <em>C. glutamicum</em>, thereby broadening its utility as a host for diverse protein production applications.</div></div>","PeriodicalId":11770,"journal":{"name":"Enzyme and Microbial Technology","volume":"191 ","pages":"Article 110725"},"PeriodicalIF":3.7000,"publicationDate":"2025-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Enzyme and Microbial Technology","FirstCategoryId":"5","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0141022925001450","RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
A hyperthermophilic β-glucosidase from Pyrococcus furiosus (PfBGL) is a highly stable and active glycoside hydrolase, well-suited for a wide range of applications. Although PfBGL has been successfully expressed in Escherichia coli, the use of this host limits its applicability in the healthcare and food processing industries due to safety concerns associated with E. coli-based expression systems. Recently, Corynebacterium glutamicum has emerged as a safe and versatile microbial platform for the expression of recombinant proteins used in food processing, pharmaceutical development, therapeutic enzyme production, and probiotic applications. Despite these advantages, heterologous expression in C. glutamicum is often hindered by low protein yields, and PfBGL expression in this host has not been previously explored. In this study, we report for the first time the production of PfBGL in C. glutamicum, achieving a 15-fold enhancement through the optimization of the promoter, the vector backbone, and the His-tag location. Among four different promoters, the Ptrc promoter with RBST7 yielded the highest PfBGL expression. For the Ptrc-RBST7 combination, the PfBGL expression levels further varied depending on the vector backbone. Interestingly, placing the His-tag at the N-terminus of PfBGL not only increased its expression in C. glutamicum, but also enhanced its enzymatic activity (kcat/Km), when compared to C-terminal tagging. Overall, this study showcases a simple yet effective strategy at both genetic and protein levels to enhance PfBGL production in C. glutamicum, thereby broadening its utility as a host for diverse protein production applications.
期刊介绍:
Enzyme and Microbial Technology is an international, peer-reviewed journal publishing original research and reviews, of biotechnological significance and novelty, on basic and applied aspects of the science and technology of processes involving the use of enzymes, micro-organisms, animal cells and plant cells.
We especially encourage submissions on:
Biocatalysis and the use of Directed Evolution in Synthetic Biology and Biotechnology
Biotechnological Production of New Bioactive Molecules, Biomaterials, Biopharmaceuticals, and Biofuels
New Imaging Techniques and Biosensors, especially as applicable to Healthcare and Systems Biology
New Biotechnological Approaches in Genomics, Proteomics and Metabolomics
Metabolic Engineering, Biomolecular Engineering and Nanobiotechnology
Manuscripts which report isolation, purification, immobilization or utilization of organisms or enzymes which are already well-described in the literature are not suitable for publication in EMT, unless their primary purpose is to report significant new findings or approaches which are of broad biotechnological importance. Similarly, manuscripts which report optimization studies on well-established processes are inappropriate. EMT does not accept papers dealing with mathematical modeling unless they report significant, new experimental data.